Back to Search
Start Over
Reply from authors re: Guillaume Ploussard, James W. Catto. The quest for an optimal definition of prostate-specific antigen failure following radical prostatectomy: the risk of not seeing the forest for the trees. Eur Urol 2014;66:211-13: Identifying the candidates for early salvage therapy after radical prostatectomy
- Source :
- European urology. 66(2)
- Publication Year :
- 2013
-
Abstract
- prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 2009;27:2924–30. [10] Goenka A, Magsanoc JM, Pei X, et al. Long-term outcomes after high-dose postprostatectomy salvage radiation treatment. Int J Radiat Oncol Biol Phys 2012;84:112–8. [11] Van der Kwast TH, Bolla M, Van Poppel H, et al. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol 2007;25:4178–86. [12] Ploussard G, Staerman F, Pierrevelcin J, et al. Predictive factors of oncologic outcomes in patients who do not achieve undetectable prostate specific antigen after radical prostatectomy. J Urol 2013; 190:1750–6.
- Subjects :
- Male
Salvage Therapy
medicine.medical_specialty
business.industry
Prostatectomy
Urology
medicine.medical_treatment
Postoperative radiotherapy
Salvage therapy
Prostatic Neoplasms
Prostate-Specific Antigen
medicine.disease
PT3 Prostate Cancer
Prostate-specific antigen
Prostate cancer
Salvage radiation
Medicine
Humans
In patient
Neoplasm Recurrence, Local
business
Subjects
Details
- ISSN :
- 18737560
- Volume :
- 66
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- European urology
- Accession number :
- edsair.doi.dedup.....c70066791d3ea47ce1735a34c69c057b